The following article was featured in:
Source:
Section Page News - Crain's New York Business
09/09/2025.
A Park Slope-based biotech startup that created a gel that stops bleeding is capitalizing on recent momentum with a mutli-million dollar infusion. Cresilon raised $17 million in a late stage venture...
Continue on to full article...
